While we did not observe any changes in gene expression for AT1 and AT2 receptors, there were alterations in the generation and metabolism of angiotensin peptides in CRC tumor tissues that could affect AT1 and AT2 receptor signaling. This evidence concerns the gene AGTR2 and colorectal carcinoma.